. Two longitudinal studies did not find any significant association between blood lead and physical growth (5, 6) . In another longitudinal study, covariate-adjusted heights at 15 and 33 months of age were negatively associated with postnatal blood lead concentrations (7, 8) .
Considering that physical growth is a time-integrated outcome, use of biomarkers of chronic exposure such as tooth lead and bone lead might be more advantageous than blood lead in investigating the association. Blood lead reflects relatively recent exposure over a few months, and the biological half-life of lead in children was several times shorter than that for adults (9, 10) . Indeed, with control for other variables, including the child's medical history, dietary history, behavior, tobacco smoking of parents, and sociodemographic factors, a study of Danish children showed an inverse association between tooth lead and height (11) .
Lead concentrates in mineralized tissue such as bone and teeth. The concentration of lead in the circumpulpal dentin of deciduous teeth has been a useful biomarker of cumulative lead exposure in studies of the chronic toxicity of lead (12) . It provides more valid information than does tooth enamel on systemic absorption of environmental lead into the body over several years prior to shedding (13) (14) (15) (16) .
Bone accumulates lead throughout life, eventually serving as the repository for 95% of an individual's lead burden (17) . Because of the long half-life of lead in bone, bone lead provides an index of cumulative exposure over decades. Direct measurement of lead in bone by means of an in vivo X-ray fluorescence (XRF) technique has been developed as a promising biomarker during the last decade (18, 19) . On the basis of the electron orbit where it provokes the emission of fluorescent photons from lead atoms, the XRF technique is classified into L-line XRF (L-XRF) and Kline XRF (K-XRF).
The K-XRF technique is relatively stable and reliable. Its accuracy is not affected by overlying skin thickness or movement, and it permits measurement of lead levels in bone cortex and marrow tissues deeper than L-XRF (20, 21) . It is noninvasive, involves low-level radiation dose (less than 2.5% of the effective dose of a chest X-ray examination in adults), and takes 15-30 min to measure one bone site (longer time renders better precision) (20, 22) .
To our knowledge, no studies examining the effect of chronic lead exposure on body mass index (weight in kilograms divided by the square of the height in meters; BMI) have been previously reported, although BMI, as an index of obesity, has long been shown to be an important risk factor for hypertension, diabetes, and coronary heart disease (23, 24) . We investigated the effect of chronic lead exposure on BMI as well as on weight and height in a cohort that was examined at a 13-year interval. We explored the cross-sectional relationship between dentin lead level and physical growth in each examination of the cohort, then assessed the longitudinal relationship between dentin lead level in child- Bone lead measurement. We measured bone lead in the tibia and patella of each patient using our prototype K-XRF instrument (ABIOMED, Inc., Danvers, MA). The physical principles, technical specifications, and validity of K-XRF instruments are described in detail elsewhere (28) (29) (30) .
In short, this instrument uses a 109Cd y-ray source to provoke the emission of fluorescent photons from target tissue that are detected, counted, and arrayed on a spectrum. The net lead signal is determined after subtraction of background counts by means of a linear least-squares algorithm. The lead fluorescence signal is then normalized to the elastic or coherently scattered X-ray signal, which arises predominantly from the calcium and phosphorus present in bone mineral. The unit of measurement is microgram of lead per gram of bone mineral.
Because the instrument provides a continuous, unbiased point estimate that oscillates around the true bone lead value, negative point estimates are sometimes produced when the true bone lead value is close to zero. The instrument also provides an estimate of uncertainty associated with each measurement, which is derived from a goodness of fit calculation of the spectrum curves and is equivalent to a single standard deviation. Although a minimum detectable limit calculation of twice this value has been proposed for interpreting a bone lead estimate for an individual (31) , use of all point estimates makes better use of the data for a population in epidemiologic studies (32, 33) . Recently, we have specifically addressed the methodological issues of using negative values and values below the conceptual limit of detection in epidemiologic studies (33) . Our experiment indicated that retaining all values of bone lead concentration provides less bias and greater efficiency in comparing the mean or median levels of bone lead of different populations.
Measurements were taken at the midshaft of the left tibia and at the left patella after each region had been washed with a 50% solution of isopropyl alcohol. The K-XRF beam collimator was seated perpendicular to the bone surface for the tibia and at 300 in the lateral direction for the patella.
Covariates. Information on potential confounding variables and effect modifiers was obtained from data collected by questionnaire and examination in 1975-1978. Age, sex, race, birth weight, mother's socioeconomic status (dichotomized by Hollingshead class I-IlI versus IV-V), medical history of chelation therapy for lead poisoning as of [1975] [1976] [1977] [1978] , and age at the time of K-XRF measurement in 1989-1990 were selected a priori as potential covariates.
Statistical analysis. The main purpose of the analysis was to relate physical growth (dependent variables) to lead biomarkers (independent variables) with control for potential covariates. Before the main analysis, extreme outliers in values of height, weight, and BMI were detected by the generalized extreme studentized deviate (ESD) many-outlier procedure, with a Bonferronicorrected level (34) . Lowess smoothing plots between covariate-adjusted dependent variables and covariate-adjusted independent variables were used to evaluate the form of the dose-response relationship and to suggest appropriate transformations of variables (35) .
Three sets of multiple linear regression models were fitted (Fig. 1) . First, to determine whether dentin lead level was crosssectionally associated with physical growth in childhood (1975) (1976) (1977) (1978) , regressions of dentin lead on each physical outcome were carried out, with control for age, sex, birth weight, and mother's socioeconomic status (model 1). Second, to determine whether the dentin lead level was prospectively associated with changes in physical growth between 7 and 20 years of age, regressions of dentin lead on each physical outcome were carried out, with control for age increase, age as of 1975-1978, sex, mother's socioeconomic status, and physical growth as of [1975] [1976] [1977] [1978] (model 2). Finally, to determine whether bone lead levels around the age of 20 years were retrospectively associated with changes in physical growth between 7 and 20 years of age, regressions of bone lead levels (i.e., tibia lead levels, patella lead levels, or mean bone lead levels) on each physical outcome were carried out, with coiAtrol for age increase, In exploratory data analyses, the lowess smoothing cu1 res of covariate-adjusted outcome variables and covariate-adjusted predictor variables were curvilinear and slightly upwardly convex. Lowess smoothing after logarithmic transformation of dentin lead levels provided a more linear fit. For the sake of interpretability of the scale, we used log1o dentin lead level in linear regression analyses.
With Table   2 ). The inclusion of a chelated subject did not appreciably change the regression coefficient for BMI change of log1o dentin lead (1 = 2.50, 95% CI, 0.27-4.74, p = 0.03). However, inclusion of the two outliers obscured the association (f = 2.48, 95% CI, 0.79-5.75, p = 0.13). There were no significant associations between log1o dentin lead and weight, or between log1o dentin lead and height.
No significant association was observed between bone lead as of [1989] [1990] 
Discussion
We observed a weak but significantly positive association between childhood dentin lead level and BMI in both cross-sectional and longitudinal analyses. A 10-fold increase in dentin lead level was associated with an increase of 1.02 kg/m2 in BMI at the age of 7 years. A 10-fold increase in dentin lead level was also associated with an increase in BMI change of 2.65 kg/m2 from age 7 to age 20.
The point estimates of the regression coefficient for weight and for change in weight were positive; those for height and for change in height were negative, but their interval estimates all included zero. Because increased BMI results from increased weight and/or decreased height, it may have served as a more sensitive indicator for the association between physical growth and chronic lead exposure in our study. Bone lead levels at the age of 20 years were not significantly associated with any physical growth changes between 7 and 20 years of age.
Because dentin lead level reflects chronic exposure to lead during the several years prior to the shedding of teeth, our findings suggest that children exposed to lead in early childhood experience greater BMI gain during the period between 7 and 20 years of age than those less exposed. It is possible that obese children ingested more environmental lead from tap water, canned foods, dusts, and paint chips during early childhood. This reverse causality can explain the cross-sectional association, but hardly the longitudinal association. In our longitudinal model, the exposure (the accumulation of lead in the tooth) obviously preceded the effect (the increase in BMI), thereby supporting the attribution of a causal role to lead.
Blood lead level was inversely associated with both height and weight in NHANES II data (3) . An association of blood lead with BMI was not examined, and the index of exposure was blood lead, not dentin lead, in the NHANES II. Thus, any comparison between this study and the NHANES II study should be made carefully. Nevertheless, it may be interesting to examine whether there is also a significant association between blood lead and BMI in the NHANES II data.
On the basis of coefficients of variation for weight (approximately 20%) and for height (approximately 5%) in our data, we estimated that the cross-sectional analysis of the 1975-1978 data (N= 236) had 80% power to detect the 7% difference in mean of weight and the 1.8% difference in mean of height. Smaller effects would not be detectable with 80% power.
Reduced pituitary responsiveness to hypothalamic stimuli in terms of growth hormone releasing factor or thyrotropinreleasing hormone has been postulated as a pathophysiologic mechanism for lead's effect on physical growth. A recent neuroendocrine study showed that peak human growth hormone and insulinlike growth factor I responses to the L-dopa insulin test were low in lead-poisoned children (26) . The authors concluded that lead-induced reduction in stature may be due to diminished human growth hormone secretion, which in turn results in reduced insulinlike growth factor I secretion, or that lead may directly inhibit insulinlike growth factor I formation. Blunted response of thyroidstimulating hormone and growth hormone to stimulatory challenge have been observed in lead-poisoned children (36) as well as in rats exposed to low-level lead (3). It is possible that our findings reflect similar endocrine effects of low-level lead exposure.
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The positive findings of this study may have resulted by chance. As we conducted multiple statistical tests using the same data set, the probability of a type I error may be larger than the nominal level of 0.05. Thus, further study with a larger sample size is encouraged to corroborate our findings.
A possible source of bias is our limited success in locating and enrolling members of the cohort for follow-up because of the increased migration from home that occurs around age 20. However, the characteristics of the population, including dentin lead levels, did not differ significantly between those who participated in this follow-up and those who did not. As physical growth and covariates were measured blindly with respect to the status of dentin and bone lead levels, observation bias is not likely.
We eliminated potential confounding effects of race and chelation by restricting the main analysis to white, nonchelated subjects. However, such potential confounding variables as food intake and parental body size were not controlled for in our study because this information was not available. We intended to reduce confounding effects of those variables by adjusting for mother's socioeconomic status. Still, it is possible that genetic (38, 3591 and nongenetic risk factors (23) for increased BMI might result in increased dentin lead levels through unknown mechanism. Further studies more thoroughly controlling for those potential confounders are awaited.
BMI is a major risk factor for elevated blood pressure (23, 24) . It has been noted that blood pressure was positively associated with blood lead levels before and after control for age, BMI, and other related factors (40) (41) (42) (43) (44) (45) . However, the association between blood lead and blood pressure is not conclusive yet (45) , because it is very weak (1 to 2 mm Hg for every doubling in blood lead levels in middle-aged men) and influenced by the inclusion of covariates in the statistical model such as alcohol consumption and cigarette smoking (41) .
Our finding that childhood lead exposure may predict increased BMI that persists into adulthood is suggestive of an indirect path to elevated blood pressure related to chronic lead exposure. If our finding is replicable and robust, the ramifications are significant. The previously described association between low-level lead exposure and elevated blood pressure may be stronger than currently assumed, if the effect of lead on obesity is also taken into account. 
